中文 | English
Return
Total: 536 , 1/54
Show Home Prev Next End page: GO
Author:( Xing-wei, WU)

1.Determination of BIS50 and ED50 for propofol during induction by sequential experimental method

Xing XU ; Xiulan WEI ; Xinmin WU

Chinese Journal of Anesthesiology 2001;21(1):7-9

2.Daily Intake of Boron through Food and Drinking Water for People Living in Different Environments

Xiaoru XING ; Guoping WU ; Fusheng WEI

Journal of Environment and Health 1993;0(03):-

3. Bioequivalence and pharmacokinetic study of glipizide by HPLC-MS/MS

Xing-Wei WU

Chinese Pharmaceutical Journal 2013;48(14):1204-1208

4.Roles of B-cell receptor signaling and its targeted inhibitors in lymphoid malignancies

Xing DAI ; Xiaoyi JIA ; Yujing WU ; Wei WEI

Chinese Pharmacological Bulletin 2014;(5):604-607

5.Meta-analysis of regimen SOX versus XELOX in treatment of Chinese patients with advanced gastric carcinoma

Yuanjun LI ; Juan XING ; Hanchang WU ; Xu WEI ; Hongmei ZHANG

Chinese Journal of Biochemical Pharmaceutics 2015;37(5):56-60

6.Clinical analysis of surgical treatment of 79 patients with primary cardiac tumors

Wei TAN ; Chaoguang WU ; Hong ZHANG ; Jie XING

Cancer Research and Clinic 2013;(3):193-194

7.Clinical value of three kinds of helicobacter pylori detection methods

Xing BAI ; Suhua WU ; Wei RAN ; Zhechuan MEI

Chongqing Medicine 2014;(29):3887-3889

8.Analysis of Contralateral High-frequency Stimulation ABR in Patients with Unilateral Sudden Deafness

Liya CHENG ; Wei BI ; Jixiang LIU ; Fei WU ; Yizhuo XING

Journal of Audiology and Speech Pathology 2014;(1):53-55

9.Pharmacokinetics of Berberine in Puerariae and Scutellariae and Coptidis Decoction in Vivo of Dog

Yanping WU ; Xiaomei TAN ; Xuefeng XING ; Wei ZHANG

China Pharmacy 2001;0(11):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 536 , 1/54 Show Home Prev Next End page: GO